Subscribe to RSS
DOI: 10.1055/s-0029-1225348
© Georg Thieme Verlag KG Stuttgart · New York
Comparison of Sufentanil versus Fentanyl in Ventilated Term Neonates
Vergleich von Sufentanil versus Fentanyl bei reifen, beatmeten NeugeborenenPublication History
Publication Date:
03 September 2009 (online)
![](https://www.thieme-connect.de/media/klinpaed/201002/lookinside/thumbnails/10.1055-s-0029-1225348-1.jpg)
Abstract
Background: Increasingly frequent applications of opioid analgesics in neonatal intensive care require the evaluation of efficacy and side effects.
Patients: Mechanically ventilated term neonates were consecutively enrolled.
Methods: In a double-blind randomized trial 20 newborns received a continuous intravenous infusion of fentanyl (n=10) or sufentanil (n=10) in an assumed equipotent dose of 7:1. The analgesic dose was individually adjusted according to sedation scores. The period between cessation of analgesic medication and successful extubation (weaning time), adverse drug effects and urinary cortisol concentrations were evaluated.
Results: No significant difference of weaning time was seen between fentanyl and sufentanil group (mean weaning time (±SD) of fentanyl group 520±381 min, median 380 min; sufentanil group 585±531 min, median 405 min, p=0.78, 2-tailed U-Test, Mann and Whitney). The mean opioid dose resulted in a 10:1 ratio (fentanyl 4.11 μg/(kg×h) vs sufentanil 0.41 μg/(kg×h)). We found no marked differences in sedation levels, blood pressure, heart rate, oxygenation index, co-medication or urinary cortisol levels. In both groups similar adverse effects were assessed including respiratory depression, mild withdrawal symptoms or decrease of gastrointestinal motility.
Conclusion: In our study sufentanil did not reduce the weaning period in ventilated term neonates when compared to fentanyl. The equipotent dose ratio for fentanyl/sufentanil was 10:1. According to sedation scores both substances provided effective pain and stress protection.
Zusammenfassung
Hintergrund: Die zunehmende Anzahl von Opioiden im Rahmen der Neugeborenenintensivtherapie legt die Untersuchung von Wirkung und potentiellen Nebenwirkungen nahe.
Patienten: Reife, aufgrund von postnatalen Atemstörungen beatmete Neugeborene wurden konsekutiv eingeschlossen.
Methode: In einer randomisierten, doppelblinden Studie erhielten 20 Neugeborene eine kontinuierliche intravenöse Infusion mit Fentanyl (n=10) oder Sufentanil (n=10) in einer angenommenen Äquivalentdosis von 7:1. Die analgetische Dosis wurde individuell gemäß Sedierungsscore angepaßt. Bewertet wurde der Zeitraum zwischen Beendigung der Analgesie und erfolgreicher Extubation (weaning), Nebenwirkungen und die Cortisol-Konzentration im Urin.
Ergebnisse: Im Vergleich Fentanyl/Sufentanil fanden sich keine signifikanten Unterschiede in Bezug auf das Weaning (mittlere Weaning Dauer (±SD) der Fentanylgruppe 520±381 min, Median 380 min; Sufentanilgruppe 585±531 min, Median 405 min, p=0.78, 2-seitiger U-Test, Mann und Whitney). Die mittlere Opioiddosis betrug für Fentanyl 4.11 μg/(kg×h) vs. Sufentanil 0.41 μg/(kg×h) entsprechend einem Verhältnis von 10:1. Wir beobachten keine nennenswerten Unterschiede bezüglich Sedierungsniveau, Blutdruck, Herzfrequenz, Oxigenierungsindex, Komedikation oder Urin-Kortisolspiegel. Beide Patientengruppen wiesen vergleichbare Charakteristika im Hinblick auf Atemdepression, milde Entzugserscheinungen oder Reduktion der gastrointestinalen Motilität auf.
Schlußfolgerung: In unserem Kollektiv konnte eine Reduktion der Weaningdauer nach Einsatz von Sufentanil im Vergleich zu Fentanyl nicht nachgewiesen werden. Die Äquipotenzdosis betrug 10:1 Fentanyl/Sufentanil. Gemäß den Sedierungsscores erzielen beide Substanzen eine Abschirmung vor Stressfaktoren.
Key words
opioid - pain - newborn - analgesia - sedation - clinical pharmacology
Schlüsselwörter
Opioid - Schmerz - Neugeborene - Analgesie - Sedierung - Pharmakologie
Literatur
- 1 Anand KJ, Hall RW, Desai N. et al . Effects of morphine analgesia in ventilated preterm neonates: primary outcomes from the NEOPAIN randomised trial. Lancet. 2004; 363 1673-1682
- 2 Anand KJS, Hickey PR. Pain and its effects in the human neonate and fetus. N Engl J Med. 1987; 317 1321-1329
- 3 Anand KJS, Sippell WG, Aynsley-Green A. Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: effects on the stress reponse. The Lancet I. 1987; 10 62-654
- 4 Angeles DM, Wycliffe N, Michelson D. et al . Use of opioids in asphyxiated term neonates: effects on neuroimaging and clinical outcome. Pediatr Research. 2005; 57 873-878
- 5 Aranda JV, Carlo W, Hummel P. et al . Analgesia and sedation during mechanical ventilation in neonates. Clin Ther.. 2005; 27 877-994
- 6 Aretz S, Licht C, Roth B. Endogenous distress in ventilated full-term newborns with acute respiratory failure. Biol Neonate. 2004; 85 243-248
- 7 Bailey PL, Streisand JB, East KA. et al . Differences in magnitude and duration of opioid-induced respiratory depression and analgesia with fentanyl and sufentanil. Anaesth Analg. 1990; 70 8-15
- 8 Bhandari V, Bergqvist LL, Kronsberg SS. et al . Morphine administration and short-term pulmonary outcomes among ventilated preterm infants. Pediatrics. 2005; 116 492-493
- 9 Bauer P, Köhne K. Evaluation of experiments with adaptive interim analyses. Biometrics. 1994; 50 1029-1041
- 10 Collins C, Koren G, Crean P. et al . Fentanyl pharmacokinetics and hemodynamic effects in preterm infants during ligation of patent ductus arteriosus. Anaesth Analg. 1985; 64 1078-1080
- 11 Escobar GJ, Fischer A, Li DK. et al . Armstrong MA Score for acute physiology: validation in three Kaiser Permanente neonatal intensive care units. Pediatrics. 1995; 96 918-922
- 12 Fahnenstich H, Steffan J, Kau N. et al . Fentanyl-induced chest wall rigidity and laryngospasm in preterm and term infants. Crit Care Med. 1995; 28 ((3)) 836-839
- 13 Franck LS, Miaskowski C. Measurement of neonatal responses to painful stimuli: A research review. J Pain Symptom Manage. 1995; 14 343-378
- 14 Gauntlett IS, Fisher DM, Hertzka RE. et al . Pharmacokinetics of fentanyl in neonatal humans and lambs: effect of age. Anesthesiology. 1988; 69 683-687
- 15 Gray JE, Richardson DK, McCormick MC. et al . Neonatal therapeutic intervention scoring system: a therapy-based severity of illness index. Pediatrics. 1992; 90 561-567
- 16 Greeley WJ, de Bruijn NP. Changes in sufentanil pharmacokinetics in the neonatal period. Anesth Analg. 1988; 67 86-90
- 17 Grunau RE, Holsti L. Long-term consequences of pain in human neonates. Semin Fetal Neonatal Med. 2006; 11 268-275
- 18 Guinsburg R, Kopeöman BI, Anand KJ. et al . Physiological, hormonal and behavioral responses to a single fentanyl dose in intubated and ventilated preterm neonates. J Pediatr. 1998; 132 954-959
- 19 Hartwig S, Roth B, Theisohn M. Clinical experience with continuous intravenous sedation using midazolam and fentanyl in the pediatric intensive care unit. Eur J Pediatr. 1991; 150 784-788
- 20 Howie MB, McSweeney TD, Ilingam RP. et al . A comparison of fentanyl-O2 and Sufentanil-O2 for cardiac anesthesia. Anesth Analg. 1985; 64 328-335
- 21 Hünseler C, Merkt V, Gerloff M. et al . Beurteilung von Schmerzempfinden und Sedierungsgrad bei beatmeten Neugeborenen und Säuglingen: Validierung eines Schmerz- und Sedierungs-Scores (Hartwig-Score). Z Geburtshilfe Neonatol. 2006; 210 ((Abstract),) , DOI:10.1055/s-2006-946245
- 22 Hünseler C, Roth B. Pharmacologic and non-pharmacologic pain-therapy in neonatology: synopsis of the current data. Klin Padiatr. 2008; 220 ((4)) 224-237
- 23 Kinney HC, Ottoson CK, White WF. Three-dimensional distribution of 3H-Naloxone binding to opiate receptors in the human fetal and infant brainstem. J Comp. 1990; Neurol 291 55-78
- 24 Koehntop DF, Rodman JH, Brundage DM. et al . Pharmacokinetics of fentanyl in neonates. Anesth Analg. 1986; 65 227-232
- 25 Leslie FM, Tso S, Hurlbut DE. Differential appearance of opiate receptor subtypes in neonatal rat brain. Life Sci. 1982; 31 1393-1396
- 26 Levine A, Cohen D, Zadik Z. Urinary free cortisol values in children under stress. J Pediatr. 1994; 125 853-857
- 27 Lindner U, Hilgendorff A, Frey G. et al . Drug utilisation in very preterm infants: any changes during the past decade?. Klin Padiatr. 2008; 220 ((4)) 238-242
- 28 Magnan J, Tiberi M. Evidence for the presence of μ-and κ-but not of δ-opiod sites in the human fetal brain. Dev Brain Res. 1989; 45 275-281
- 29 Menon G, Anand KJ, McIntosh N. Practical approach to analgesia and sedation in the neonatal intensive care unit. Semin Perinatol. 1998; 22 417-427
- 30 Roth B, Schluender C, Houben F. et al . Analgesia and sedation in neonatal intensive care using fentanyl by continuous infusion. Dev Pharmacol Ther. 1991; 17 121-127
- 31 Saarenmaa E, Huttunen P, Leppaluoto J. et al . Advantages of fentanyl over morphine in analgesia for ventilated newborn infants after birth: A randomized trial. J Pediatr. 1999; 134 ((2)) 144-150
- 32 Sanford TJ, Smith NT, Dec-Silver H. et al . A comparison of morphine, fentanyl and sufentanil anesthesia for cardiac surgery. Anesth Analg. 1986; 65 259-266
- 33 Santeiro ML, Christie J, Stromquist C. et al . Pharmacokinetics of continuous infusion fentanyl in newborns. J Perinatol. 1997; 17 135-139
- 34 Scholz J, Steinfath M, Schulz M. Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. Clin Pharmacokinet. 1996; 31 275-292
- 35 Simons Sh, Tibboel D. Pain perception development and maturation. Semin Fetal Neonatal Med. 2006; 11 227-231
- 36 Stanley TH, deLange S. Comparison of sufentanil-oxygen and fentanyl-oxygen anesthesia for mitral and aortic valvular surgery. J Cardiothoracic Anesth. 1988; 2 6-11
- 37 Seguin JH, Erenberg A, Leff RD. Safety and efficacy of sufentanil therapy in the ventilated infant. Neonatal Network. 1994; 13 37-40
- 38 Siamopoulou-Mavridou A, Mavridis AK, Vizandiadis A. et al . Free urinary cortisol immunoreactive levels in premature and full term infants. Acta Paediatr Scand. 1986; 75 919-922
- 39 Zadik Z, Amer R, Dolfin Z. et al . Urinary free cortisol (UFC) values in newborns under stress. J Pediatr Endocrinol Metab. 1999; 12 543-547
Correspondence
Prof. Dr. Bernhard Roth
Department of Neonatology and Pediatric Intensive Care Medicine
Children`s Hospital
University of Cologne
Kerpenerstr. 62
50937 Cologne
Germany
Email: bernhard.roth@uk-koeln.de